Sep 2019

ANTG’S COO JAMES GASKELL ON THE ACT’S LEGALISATION OF CANNABIS FOR PERSONAL USE

With the ACT becoming the first Australian jurisdiction to legalise the possession and cultivation of cannabis for personal use, the often stigmatized ‘drug’ is once again being debated in the media. ANTG’s Chief Operating Officer, James Gaskell, joins 2SER Breakfast on 107.3 to discuss his thoughts on the recent legalisation, the conflict of state vs federal laws, and the medicinal cannabis industry in Australia and abroad. Listen to his interview here.

We’re thrilled to announce we have received our export licence from the Drug Control Section of the ODC (Office of Drug Control). We’re firmly on course to continue to lead the way and be the first medicinal cannabis company in Australia to export cannabis flower to the EU since export was legalised in 2018.

READ MORE >

We have successfully passed three consecutive TGO93 and TGO100 tests on our medicinal cannabis products since our first commercial harvest at the end of 2019.

READ MORE >

One of ANTG’s proprietary medicinal cannabis strains, EVE Cannabis Indica, has been listed on the Australian Register of Therapeutic Goods (ARTG). The ARTG is a reference of therapeutic goods that can lawfully be supplied in or exported from Australia.

READ MORE >

We are focused on research and development, partnering with leading scientists and medical institutions to develop cannabinoid medicines that offer safe and effective therapeutic benefits.

LEARN ABOUT ANTG HERE >